Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Inari Medical, Inc. (NARI)

75   -0.75 (-0.99%) 11-25 13:00
Open: 75.03 Pre. Close: 75.75
High: 75.38 Low: 74.5
Volume: 180,083 Market Cap: 4,024(M)

Technical analysis

as of: 2022-11-25 1:58:59 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 97.92     One year: 114.37
Support: Support1: 72.02    Support2: 64.72
Resistance: Resistance1: 83.83    Resistance2: 97.92
Pivot: 75.85
Moving Average: MA(5): 76.53     MA(20): 75.48
MA(100): 74.72     MA(250): 76.42
MACD: MACD(12,26): 0.9     Signal(9): 1
Stochastic oscillator: %K(14,3): 57.3     %D(3): 61.7
RSI: RSI(14): 48.5
52-week: High: 100  Low: 50.5
Average Vol(K): 3-Month: 804 (K)  10-Days: 572 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NARI ] has closed above bottom band by 45.5%. Bollinger Bands are 38.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 77.94 - 78.68 78.68 - 79.14
Low: 73.67 - 74.65 74.65 - 75.24
Close: 74.63 - 76.22 76.22 - 77.18

Company Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Headline News

Sat, 26 Nov 2022
Ram Rattan Group: Vijay Chaudhary's Creative Vision in AGRI-FARM Real Estate — Transcontinental Times - Transcontinental Times

Fri, 25 Nov 2022
Gujarat Elections 2022 | Nari Shakti At The Grassroots - Are Things Changing? | English News - News18

Fri, 25 Nov 2022
This is a Testament to India's Nari Shakti, and How Women of the Country Are Leading the ... - Latest Tweet - LatestLY

Tue, 22 Nov 2022
Insider Selling: Inari Medical, Inc. (NASDAQ:NARI) COO Sells 9000 Shares of Stock - MarketBeat

Mon, 21 Nov 2022
Purvottar Swabhiman Utsav honors Veer Nari of India organised at Narangi Military Station in North East - IBG NEWS

Thu, 17 Nov 2022
NARI of Greater Chicagoland Elects New Leadership, Board of Directors for 2023-2024 - Daily Herald

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 54 (M)
Shares Float 49 (M)
% Held by Insiders 14.3 (%)
% Held by Institutions 92.7 (%)
Shares Short 5,160 (K)
Shares Short P.Month 5,770 (K)

Stock Financials

EPS -0.01
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.73
Profit Margin (%) -6.3
Operating Margin (%) -3.3
Return on Assets (ttm) -1.9
Return on Equity (ttm) -6.9
Qtrly Rev. Growth 31.8
Gross Profit (p.s.) 4.7
Sales Per Share 6.69
EBITDA (p.s.) -0.14
Qtrly Earnings Growth 0
Operating Cash Flow -10 (M)
Levered Free Cash Flow 2 (M)

Stock Valuations

PE Ratio -7500
PEG Ratio -2.2
Price to Book value 9.68
Price to Sales 11.21
Price to Cash Flow -393.72

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.